Advertisement

Ads Placeholder
Loading...

Haleos Labs Limited

HALEOSLABS.NS•NSE
Healthcare
Biotechnology
₹1287.70
₹33.90(2.70%)
Indian Market opens in 34h 48m

Haleos Labs Limited (HALEOSLABS.NS) Stock Overview

Explore Haleos Labs Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio20.82
EPS (TTM)$65.70
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$1417.97
3 Months$1907.49
1 Year Target$3185.75

HALEOSLABS.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleos Labs Limited (HALEOSLABS.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3185.75.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.82 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.70%
5-Day Change
5.34%
1-Month Change
0.51%
3-Month Change
-4.90%
6-Month Change
-1.02%
Year-to-Date (YTD) Change
-1.70%
1-Year Change
-1.02%
3-Year Change
-1.02%
5-Year Change
-1.02%
All-Time (Max) Change
-1.02%

Contact Information

https://www.smslife.in
91 40 6628 8888
Plot No. 19-III, Hyderabad, NaN, 500096

Company Facts

5,920 Employees
IPO DateNov 17, 2025
CountryIN
Actively Trading

Frequently Asked Questions